ANALIZE MEDICALE DE LABORATOR
            Aici gasiti analizele medicale grupate pe categorii precum si detalii generale si specifice pentru categoriile respective.
            Selectati o categorie din lista de mai jos:
            
         
     
    
    
    
        Solutie antistress!
 Construieste poduri :)
        
        
        Prinde pisica neagra :)
        
     
 
'Freezing' Kidney Tumors Nonsurgically Is Effective, Safe And Less Expensive Than Laparoscopic Surgery
Research presented today at 
the Society of Interventional Radiology's 32nd Annual Scientific Meeting  
shows that the nonsurgical image-guided treatment of kidney tumors -- 
cryoablation - - is as effective as the laparoscopic technique in viable 
candidates. The comparative trial shows that percutaneous cryoablation 
results in a slightly lower recurrence rate of the tumor, a shorter 
hospital stay, no major complications, and a 59.5 percent lower hospital 
cost than the laparoscopic treatment. During cryoablation argon gas enters 
the tip of the probe and extracts heat from the surrounding cells, 
resulting in an "ice ball" that freezes and kills the tumor. The 
nonsurgical treatment spares the majority of the healthy kidney tissue and 
can be repeated as often as needed. This interventional treatment had no 
major complications as opposed to the surgical group, which experienced 
complications in six percent of those studied.
 
The radiologist uses imaging to pinpoint the tumor, and then inserts 
the cryoprobe through the skin, similar to the way a biopsy is performed. 
This can be performed under general anesthesia, but is often possible with  
only local anesthesia and conscious sedation. By using imaging the 
radiologist can avoid going through any adjacent structures or harming 
healthy tissue. If necessary, adjacent structures can be displaced prior to 
the ablation to minimize collateral damage. Laparoscopy, on the other hand, 
requires general anesthesia, as well as multiple abdominal incisions to 
allow access for the surgical instruments. It is also associated with a 
longer recovery time.
 
"This early stage research indicates that percutaneous cryoablation in 
the appropriate patient population can effectively kill tumors, while also 
offering patients a shorter hospital stay, a faster recovery, and an 
excellent safety profile, all at a lower cost than laparoscopy," noted 
study author J. Louis Hinshaw, M.D., of the University of Wisconsin. 
"Unfortunately, not all patients are viable candidates for percutaneous 
ablation and we work closely with our urology colleagues to ensure that 
each patient receives the most appropriate treatment."
  
 
The FDA has approved both radiofrequency ablation and cryoablation for 
use in soft tissue tumors, of which renal cell carcinoma is one.
 
"We are excited about this study because it offers patients with renal 
cell carcinoma a less traumatic treatment that can be repeated as needed," 
Hinshaw added. "Depending on the stage of the disease, this procedure can  
be curative, but can also be used for palliative treatment in some 
settings."
 
 
In the study, 19 percutanous and 48 laparoscopic cryoablations were 
performed and compared. The results indicated:
 
-- Laparoscopic cryoablation had a slightly higher tumor recurrence rate ( 
       12.5 vs. 10.5 percent)
 
    -- Percutaneous cryoablation required fewer days in the hospital (1.1 vs. 
       2.5)
 
    -- Percutaneous cryoablation had no major complications (0 vs. 6.3 
       percent)
 
    -- Percutaneous cryoablation cost 59.5 percent less than laparoscopic 
       approach
 
About Kidney Cancer
 
    
Kidney cancer is the eighth most common cancer in men and the tenth in 
women. The most common type of kidney cancer is renal cell carcinoma that  
forms in the lining of the renal tubules in the kidney that filter the 
blood and produce urine. Approximately eighty-five percent of kidney tumors 
are renal cell carcinomas.
 
 
Surgical removal of tumors confined to the kidney offers the best 
chance for a cure. Unfortunately, some patients may not tolerate surgery 
due to underlying medical conditions, and some patients, particularly those  
with small tumors, may not want to have surgery for their cancer. In this 
group of patients, minimally invasive image-guided therapies offer a less 
invasive option. These interventional treatments can also offer valuable 
benefits to some patients with advanced or metastatic renal cell carcinoma. 
Chemotherapy drugs and radiation are generally ineffective at curing kidney 
cancer.
 
More than 32,000 Americans each year are diagnosed with kidney cancer 
-- many of them don't have symptoms. Typically, those with kidney cancer 
are past the age of 40 and are twice as likely to be men. Other risk 
factors include smoking, obesity, high blood pressure, long-term dialysis 
and Von Hippel- Lindau syndrome.
 
About the Society of Interventional Radiology
 
    
Interventional radiologists are board-certified physicians who 
specialize in minimally invasive, targeted treatments. They offer the most 
in-depth knowledge of the least invasive treatments available coupled with 
diagnostic and clinical experience across all specialties. They use X-rays,  
MRI and other imaging to advance a catheter in the body, usually in an 
artery, to treat at the source of the disease nonsurgically. As the 
inventors of peripheral angioplasty and the catheter-delivered stent, 
interventional radiologists pioneered minimally invasive modern medicine, 
and provide treatments that offer less risk, less pain and less recovery 
time compared to open surgery. More information can be found at 
http://www.SIRweb.org.
 
Society of Interventional Radiology
http://www.sirweb.org
		
"Îngheþarea" tumorile renale Nonsurgically este eficientã, în condiþii de siguranþã ºi mai puþin costisitoare decât Chirurgie Laparoscopica - 'Freezing' Kidney Tumors Nonsurgically Is Effective, Safe And Less Expensive Than Laparoscopic Surgery - articole medicale engleza - startsanatate